Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Immunologic Research|December 16, 2011
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agentsPhilippe A GallayDrug Design, Development and Therapy|February 27, 2013
Profile of alisporivir and its potential in the treatment of hepatitis CPhilippe A Gallay, Kai LinImmunologic Research|February 22, 2014
HCV core protein and virus assembly: what we know without structuresKatarzyna Gawlik, Philippe A GallayBiochimica Et Biophysica Acta|December 3, 2014
The role of immunophilins in viral infectionSam Hopkins, Philippe A GallayCurrent Opinion in Virology|June 1, 2014
Hepatitis C NS5A protein: two drug targets within the same protein with different mechanisms of resistancePrecious J Lim, Philippe A GallayScientific Reports|March 22, 2023
Acute antagonism in three-drug combinations for vaginal HIV prevention in humanized micePhilippe A Gallay, Christina M Ramirez, Marc M BaumFrontiers in Pharmacology|July 24, 2024
Cyclophilin inhibition as a strategy for the treatment of human diseaseWinston T Stauffer, Asha Z Goodman, Philippe A GallayJournal of Virology|February 12, 2002
trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activityAndrew C S Saphire, Michael D Bobardt, Philippe A GallayJournal of Virology|April 5, 2002
Cyclophilin a plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculationAndrew C S Saphire, Michael D Bobardt, Philippe A GallayPageof 6